IndraLab

Statements


| 2

reach
"Momelotinib (formerly known as CYT387) is a small-molecule, adenosine triphosphate-competitive inhibitor of JAK1 and JAK2."

reach
"Second generation JAK inhibitorsMomelotinib (CYT387, Gilead), is a small-molecule, adenosine triphosphate-competitive inhibitor of JAK1 and JAK2."